Supercritical fluid chromatography coupled with tandem mass spectrometry: A high-efficiency detection technique to quantify Taxane drugs in whole-blood samples.

We present a technique to rapid determine taxane in blood samples by supercritical fluid chromatography together with mass spectrometry. The aim of this study was to develop a supercritical fluid chromatography with mass spectrometry method for the analysis of paclitaxel, cabazitaxel, and docetaxel in whole-blood samples of rats. Liquid-dry matrix spot extraction was selected in sample preparation procedure. Supercritical fluid chromatography separation of paclitaxel, cabazitaxel, docetaxel, and glyburide (internal standard) was accomplished within 3 min by using the gradient mobile phase consisted of methanol as the compensation solvent and carbon dioxide at a flow rate of 1.0 mL/min. The method was validated regarding specificity, the lower limit of quantification, repeatability, and reproducibility of quantification, extraction recovery, and matrix effects. The lower limit of quantification was found to be 10 ng/mL since it exhibited acceptable precision and accuracy at the corresponding level. All interday accuracies and precisions were within the accepted criteria of ±15% of the nominal value and within ±20% at the lower limit of quantification, implying that the method was reliable and reproducible. In conclusion, this method is a promising tool to support and improve preclinical or clinical pharmacokinetic studies with the taxanes anticancer drugs.

[1]  Y. Vander Heyden,et al.  Is the solvation parameter model or its adaptations adequate to account for ionic interactions when characterizing stationary phases for drug impurity profiling with supercritical fluid chromatography? , 2016, Analytica chimica acta.

[2]  Han‐Gon Choi,et al.  Development of RP-HPLC method for simultaneous determination of docetaxel and curcumin in rat plasma: Validation and stability , 2016, Asian journal of pharmaceutical sciences.

[3]  A. Manjappa,et al.  Mixed Micelles as Nano Polymer Therapeutics of Docetaxel: Increased In vitro Cytotoxicity and Decreased In vivo Toxicity. , 2017, Current drug delivery.

[4]  V. Sarma,et al.  LC-ESI-MS/MS determination of paclitaxel on dried blood spots. , 2012, Biomedical chromatography : BMC.

[5]  S. Bermingham,et al.  Simultaneous determination of anthracyclines and taxanes in human serum using online sample extraction coupled to high performance liquid chromatography with UV detection. , 2010, Journal of separation science.

[6]  M. Birrer,et al.  Spleen Tyrosine Kinase Confers Paclitaxel Resistance in Ovarian Cancer. , 2015, Cancer cell.

[7]  E. Forgács Use of porous graphitized carbon column for determining taxol inTaxus baccata , 1994 .

[8]  Martial Saugy,et al.  Liquid chromatography and supercritical fluid chromatography as alternative techniques to gas chromatography for the rapid screening of anabolic agents in urine. , 2016, Journal of chromatography. A.

[9]  H. Bloemendal,et al.  Towards better dose individualisation: metabolic phenotyping to predict cabazitaxel pharmacokinetics in men with prostate cancer , 2017, British Journal of Cancer.

[10]  J. Schellens,et al.  Quantification of cabazitaxel, its metabolite docetaxel and the determination of the demethylated metabolites RPR112698 and RPR123142 as docetaxel equivalents in human plasma by liquid chromatography-tandem mass spectrometry. , 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[11]  A. Pandey,et al.  Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules. , 2015, Cancer cell.

[12]  Jason Hu,et al.  Impact of abiraterone acetate with and without prior docetaxel chemotherapy on the survival of patients with metastatic castration-resistant prostate cancer: a population-based study. , 2017, CMAJ open.

[13]  H. Issaq,et al.  Separation of taxol and related compounds by micellar electrokinetic chromatography , 1994 .

[14]  George P. Kim nab-Paclitaxel for the treatment of pancreatic cancer , 2017, Cancer management and research.

[15]  R. Perez-soler,et al.  Emerging treatment using tubulin inhibitors in advanced non-small cell lung cancer , 2017, Expert opinion on pharmacotherapy.

[16]  Saumitra Das,et al.  Interplay between NS3 protease and human La protein regulates translation-replication switch of Hepatitis C virus , 2011, Scientific reports.

[17]  Yongjun Wang,et al.  Detection of related substances in polyene phosphatidyl choline extracted from soybean and in its commercial capsule by comprehensive supercritical fluid chromatography with mass spectrometry compared with HPLC with evaporative light scattering detection. , 2015, Journal of separation science.

[18]  He Lian,et al.  Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery. , 2011, International journal of pharmaceutics.

[19]  E. Wiemer,et al.  Quantification of cabazitaxel in human plasma by liquid chromatography/triple-quadrupole mass spectrometry: a practical solution for non-specific binding. , 2012, Journal of pharmaceutical and biomedical analysis.

[20]  H. Taubert,et al.  Cabazitaxel operates anti-metastatic and cytotoxic via apoptosis induction and stalls brain tumor angiogenesis , 2016, Oncotarget.

[21]  N. K. Tripathy,et al.  LC-MS / MS Determintion of Cabazitaxel in Rat Whole Blood on Dry Blood Spots , 2012 .

[22]  S. Lehmann,et al.  Current and future use of “dried blood spot” analyses in clinical chemistry , 2013, Clinical chemistry and laboratory medicine.